Sequenom Shares Pushed Upward in November as Decode Collapsed

Decode's shares sank to a few pennies after the firm filed for bankruptcy protection. Meanwhile, Sequenom rose as it attempts rebound from a major setback in its Down syndrome test development program.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.